{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:19:49Z","timestamp":1715998789478},"reference-count":68,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jns.2012.10.020","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T09:45:15Z","timestamp":1352540715000},"page":"37-42","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1016","volume":"333","author":[{"given":"Emily K.","family":"Mathey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2012.10.020_bb0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"issue":"12 Suppl. 6","key":"10.1016\/j.jns.2012.10.020_bb0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.59.12_suppl_6.S2","article-title":"Diagnosis of CIDP","volume":"59","author":"Latov","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2012.10.020_bb0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/brain\/53.3.278","article-title":"Chronic progressive polyneuritis, with report of a fatal case","volume":"53","author":"Hyland","year":"1930","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jns.2012.10.020_bb0020","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"issue":"Pt 7","key":"10.1016\/j.jns.2012.10.020_bb0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/122.7.1383","article-title":"Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy","volume":"122","author":"Duggins","year":"1999","journal-title":"Brain"},{"issue":"2\u20133","key":"10.1016\/j.jns.2012.10.020_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(87)90097-9","article-title":"Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit","volume":"81","author":"Harvey","year":"1987","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.jns.2012.10.020_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-5728(86)90059-7","article-title":"Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Pollard","year":"1986","journal-title":"J Neuroimmunol"},{"issue":"Pt 4","key":"10.1016\/j.jns.2012.10.020_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/brain\/118.4.857","article-title":"Intraneural activated T cells cause focal breakdown of the blood-nerve barrier","volume":"118","author":"Spies","year":"1995","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.10.020_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-5728(94)00164-J","article-title":"Synergy between antibody and P2-reactive T cells in experimental allergic neuritis","volume":"57","author":"Spies","year":"1995","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.jns.2012.10.020_bb0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00684474","article-title":"Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study","volume":"18","author":"Prineas","year":"1971","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.jns.2012.10.020_bb0065","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.wnl.0000188879.19900.b7","article-title":"Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP","volume":"65","author":"Sommer","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2012.10.020_bb0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/eji.1830180622","article-title":"Specific lysis by CD8+ T cells of Schwann cells expressing Mycobacterium leprae antigens","volume":"18","author":"Steinhoff","year":"1988","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jns.2012.10.020_bb0075","series-title":"The biology of Schwann cells","first-page":"171","article-title":"Chronic idiopathic demyelinating polyneuropathy and Schwann cells","author":"Pollard","year":"2007"},{"issue":"Pt 4","key":"10.1016\/j.jns.2012.10.020_bb0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2012.10.020_bb0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(84)90136-9","article-title":"Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G","volume":"66","author":"Heininger","year":"1984","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.10.020_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-5728(93)90255-W","article-title":"Antibody responses to P0 and P2 myelin proteins in Guillain\u2013Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy","volume":"46","author":"Khalili-Shirazi","year":"1993","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.10.020_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","article-title":"Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"73","author":"Melendez-Vasquez","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(99)00269-6","article-title":"Anti-PMP22 antibodies in patients with inflammatory neuropathy","volume":"104","author":"Gabriel","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(99)00250-7","article-title":"Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies","volume":"104","author":"Ritz","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.jns.2012.10.020_bb0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann Neurol"},{"issue":"Pt 2","key":"10.1016\/j.jns.2012.10.020_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/brain\/awg030","article-title":"Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies","volume":"126","author":"Kwa","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J Peripher Nerv Syst"},{"issue":"10","key":"10.1016\/j.jns.2012.10.020_bb0130","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.4049\/jimmunol.1200493","article-title":"Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy","volume":"188","author":"Su","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2012.10.020_bb0135","first-page":"261","article-title":"A new Aire-deficient model of spontaneous autoimmune peripheral neuropathy","volume":"17","author":"Nagavalli","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"107","author":"Ilyas","year":"1992","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(96)00042-2","article-title":"Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"70","author":"Yuki","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12104-011-9317-2","article-title":"(1)H, (1)(3)C, and (1)(5)N resonance assignment of the SPFH domain of human stomatin","volume":"6","author":"Tsuruta","year":"2012","journal-title":"Biomol NMR Assign"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.10.020_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.016","article-title":"Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"239","author":"Kuwahara","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2012.10.020_bb0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-61779-373-8_28","article-title":"Combinatorial glycoarray","volume":"808","author":"Rinaldi","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.plipres.2009.09.001","article-title":"Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding","volume":"49","author":"Rinaldi","year":"2010","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0170","first-page":"99","article-title":"In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study","volume":"95","author":"Saida","year":"1979","journal-title":"Am J Pathol"},{"issue":"4397","key":"10.1016\/j.jns.2012.10.020_bb0175","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.451555","article-title":"Experimental allergic neuritis induced by sensitization with galactocerebroside","volume":"204","author":"Saida","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jns.2012.10.020_bb0180","series-title":"Peripheral neuropathy","first-page":"573","article-title":"Periperal nerve antigens","author":"Willison","year":"2005"},{"issue":"15","key":"10.1016\/j.jns.2012.10.020_bb0185","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.10.020_bb0190","unstructured":"David M, Spies JM, Pollard JD, Armati PJ, Zhang G. Anti-ganglioside antibodies induce axonal conduction failure. Submitted for publication."},{"issue":"10","key":"10.1016\/j.jns.2012.10.020_bb0195","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0200","doi-asserted-by":"crossref","first-page":"e14533","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of Ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Cifuentes-Diaz","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain\u2013Barre syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"20","key":"10.1016\/j.jns.2012.10.020_bb0210","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1073\/pnas.0901496106","article-title":"Contactin-2\/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals","volume":"106","author":"Derfuss","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2012.10.020_bb0220","first-page":"288","article-title":"Antineurofascin antibodies are present in patients with peripheral demyelinating neuropathies and mediate changes in nerve conductin in animals","volume":"15","author":"Yan","year":"2010","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1529-8027.2011.00323.x","article-title":"CIDP \u2014 the relevance of recent advances in Schwann cell\/axonal neurobiology","volume":"16","author":"Pollard","year":"2011","journal-title":"J Peripher Nerv Syst"},{"issue":"5","key":"10.1016\/j.jns.2012.10.020_bb0230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ana.22693","article-title":"Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis","volume":"71","author":"Dhaunchak","year":"2012","journal-title":"Ann Neurol"},{"issue":"Pt 1","key":"10.1016\/j.jns.2012.10.020_bb0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0240","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0245","first-page":"CD002062","article-title":"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jns.2012.10.020_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.1142","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2003-41130","article-title":"The treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Kissel","year":"2003","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.jns.2012.10.020_bb0260","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.62.4.388","article-title":"Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study","volume":"62","author":"Molenaar","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12 Suppl. 6","key":"10.1016\/j.jns.2012.10.020_bb0265","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.59.12_suppl_6.S22","article-title":"Therapy of CIDP and related immune-mediated neuropathies","volume":"59","author":"Koski","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jns.2012.10.020_bb0270","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneur.65.11.1460","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids","volume":"65","author":"Muley","year":"2008","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.jns.2012.10.020_bb0275","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jns.2012.10.020_bb0280","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"7678","key":"10.1016\/j.jns.2012.10.020_bb0285","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(70)92019-2","article-title":"Treatment of polyneuropathy with azathioprine","volume":"2","author":"Yuill","year":"1970","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jns.2012.10.020_bb0290","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.35.8.1173","article-title":"Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy","volume":"35","author":"Dyck","year":"1985","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2012.10.020_bb0295","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000095139","article-title":"Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: an open-label study","volume":"56","author":"Radziwill","year":"2006","journal-title":"Eur Neurol"},{"issue":"1","key":"10.1016\/j.jns.2012.10.020_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1085-9489.2005.10104.x","article-title":"High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy","volume":"10","author":"Gladstone","year":"2005","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"10.1016\/j.jns.2012.10.020_bb0310","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8","article-title":"Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy","volume":"21","author":"Barnett","year":"1998","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.jns.2012.10.020_bb0315","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2012.10.020_bb0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1529-8027.2011.00334.x","article-title":"Novel treatment for immune neuropathies on the horizon","volume":"16","author":"Hartung","year":"2011","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"10.1016\/j.jns.2012.10.020_bb0325","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-009-5437-3","article-title":"Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy","volume":"257","author":"Marsh","year":"2010","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.jns.2012.10.020_bb0330","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2012.10.020_bb0335","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1529-8027.2010.00284.x","article-title":"Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice","volume":"15","author":"Gorson","year":"2010","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"10.1016\/j.jns.2012.10.020_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12005771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12005771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T14:20:16Z","timestamp":1540131616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X12005771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0022510X12005771"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.10.020","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inflammatory demyelinating polyneuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2012.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2012 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}